These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 15216451
21. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. Bolanowski M, Daroszewski J, Medraś M, Zadrozna-Sliwka B. J Bone Miner Metab; 2006; 24(1):72-8. PubMed ID: 16369902 [Abstract] [Full Text] [Related]
22. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V, Liuzzi A. Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749 [Abstract] [Full Text] [Related]
23. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers. Harel Z, Gold M, Cromer B, Bruner A, Stager M, Bachrach L, Wolter K, Reid C, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson C, Burkman R, Bone H. J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205 [Abstract] [Full Text] [Related]
24. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly. Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR, Farias ML. Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022 [Abstract] [Full Text] [Related]
25. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism. Kosowicz J, El Ali Z, Ziemnicka K, Sowinski J. J Clin Densitom; 2007 Dec; 10(3):332-9. PubMed ID: 17470407 [Abstract] [Full Text] [Related]
26. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Malik P, Gasser RW, Kemmler G, Moncayo R, Finkenstedt G, Kurz M, Fleischhacker WW. Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976 [Abstract] [Full Text] [Related]
27. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J. Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887 [Abstract] [Full Text] [Related]
28. Bone metabolism and mineral density in patients with beta-thalassemia major. Dundar U, Kupesiz A, Ozdem S, Gilgil E, Tuncer T, Yesilipek A, Gultekin M. Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474 [Abstract] [Full Text] [Related]
29. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB. Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406 [Abstract] [Full Text] [Related]
30. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine. Kayath MJ, Vieira JG. Osteoporos Int; 1997 Dec; 7(3):226-30. PubMed ID: 9205635 [Abstract] [Full Text] [Related]
31. Relationship between bone turnover and bone density at the proximal femur in stroke patients. Paker N, Bugdayci D, Tekdos D, Dere C, Kaya B. J Stroke Cerebrovasc Dis; 2009 Dec; 18(2):139-43. PubMed ID: 19251190 [Abstract] [Full Text] [Related]
32. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution. Jallad RS, Musolino NR, Salgado LR, Bronstein MD. Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910 [Abstract] [Full Text] [Related]
33. Growth hormone and bone mineral densitiy in HIV-1-infected male subjects. Teichmann J, Lange U, Discher T, Lohmeyer J, Stracke H, Bretzel RG. Eur J Med Res; 2008 Apr 30; 13(4):173-8. PubMed ID: 18504173 [Abstract] [Full Text] [Related]
34. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2007 Oct 30; 67(4):485-92. PubMed ID: 17561977 [Abstract] [Full Text] [Related]
35. Bone mass density in adults with sickle cell disease. Sarrai M, Duroseau H, D'Augustine J, Moktan S, Bellevue R. Br J Haematol; 2007 Feb 30; 136(4):666-72. PubMed ID: 17223909 [Abstract] [Full Text] [Related]
36. [Duration of the effect of growth hormone on spongious bone]. Zák J, Kapitola J, Povýsil C, Haas T. Sb Lek; 1999 Feb 30; 100(3):235-41. PubMed ID: 11221471 [Abstract] [Full Text] [Related]
37. Low lumbar spine bone mineral density in both male and female endurance runners. Hind K, Truscott JG, Evans JA. Bone; 2006 Oct 30; 39(4):880-5. PubMed ID: 16682267 [Abstract] [Full Text] [Related]
38. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure? Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM. Clin Endocrinol (Oxf); 2005 Apr 30; 62(4):410-7. PubMed ID: 15807870 [Abstract] [Full Text] [Related]
39. Prostatic disorders in acromegalic patients experience of a Brazilian center. Corrêa LL, Balarini Lima GA, Cavallieri SA, Miranda LC, Gadelha MR. Int Braz J Urol; 2013 Apr 30; 39(3):393-401. PubMed ID: 23849571 [Abstract] [Full Text] [Related]
40. Bone mineral density of both genders in Type 1 diabetes according to bone composition. Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A, Raptis SA. J Diabetes Complications; 2006 Apr 30; 20(5):302-7. PubMed ID: 16949517 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]